DCN and neoplasm: In tumor cells, decorin inhibits tyrosine kinase receptors, such as epidermal growth factor receptor, type I insulin-like growth factor receptor, and hepatocyte growth factor receptor (or mesenchymal-epithelial transition factor) (14,15).